1^ST ASNO Webinar

Introduction

Se-Hyuk Kim Scientific Chair of WFNOS 2022, Korea

Welcome Address

Ryo Nishikawa President of ASNO, Japan

Yong-Kil Hong President of WFNOS, Korea

Session: Updates in Neuro-Oncology

Lecture 1	Updates on the management of low grade gliomas (20 mins. + 5 mins. Q&A)
Julette Batara St. Luke’s Medical Center, The Philippines
Lecture 2	Biomarkers for glioblastoma (20 mins. + 5 mins. Q&A)
Mitsutoshi Nakada Kanazawa University, Japan
Lecture 3	Survivals and survivorship in adolescent and young adult CNS tumor population (20 mins. + 5 mins. Q&A)
Rakesh Jalali Apollo Proton Cancer Centre, India
Lecture 4	Management of brain tumor in resource limited setting – the LMIC perspective (20 mins. + 5 mins. Q&A)
Ather Enam The Aga Khan University, Pakistan
Closing

2^nd ASNO Webinar

Introduction & Welcome Address

Seok-Gu Kang Executive Chair, Scientific Committee of WFNOS

Ryo Nishikawa President of ASNO

Session: Updates in Neuro-Oncology

Moderators
Sith Sathornsumetee Thailand	Julette Batara The Philippines

Lecture 1	PCNSL – Current standard of care and novel therapeutic development (25 mins. + 5 mins. Q&A)
Motoo Nagane Kyorin University, Japan
Lecture 2	Vasculogenic mimicry: potential therapeutic target of glioma (25 mins. + 5 mins. Q&A)
Zhong-ping Chen Sun Yat-Sen University, China
Lecture 3	The QOL and survivorships in childhood survivors of brain tumor (25 mins. + 5 mins. Q&A)
Hsiu-Ju Yen Taipei Veterans General Hospital, Taiwan
Lecture 4	Challenges in risk stratification of medulloblastoma in molecular era (25 mins. + 5 mins. Q&A)
Ji Won Lee Sungkyunkwan University, Korea
Closing Address
Yong-Kil Hong President of WFNOS